COMGEN BIOPHARMACEUTICAL
Kangjing Bio focuses on the research and development of innovative drugs for the immunotherapy of autoimmune diseases and tumors. A round of financing of nearly 100 million yuan has been completed. This round of financing was jointly led by Sequoia China and Yahui Investment, followed by Fuchuang Investment and Renyou Investment. For this transaction, Hejun Capital and Chenrui Capital acted as financial advisors. This round of financing will be mainly used for phase I clinical trials of complement inhibitors under research on new targets, the advancement of other pipeline drugs, and the further consolidation of the application of innovative drug research and development platforms based on the complement system.
COMGEN BIOPHARMACEUTICAL
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2017-06-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.comgenpharma.com
Total Employee:
11+
Status:
Active
Contact:
+86-21-68822018
Total Funding:
0
Similar Organizations
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Investors List
Yahui Precision Medicine Fund
Yahui Precision Medicine Fund investment in Series A - ComGen Biopharmaceutical
Fudan Venture Capital
Fudan Venture Capital investment in Series A - ComGen Biopharmaceutical
Sequoia Capital China
Sequoia Capital China investment in Series A - ComGen Biopharmaceutical
Official Site Inspections
http://www.comgenpharma.com
- Host name: 120.133.60.61
- IP address: 120.133.60.61
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "ComGen Biopharmaceutical"
Shanghai ComGen Biopharmaceutical Co., Ltd.
The complement system is a key component of innate immunity and an important link of innate immunity and acquired immunity. It functions to eliminate invading pathogens, cell debris and …See details»
Innovative drug development_Autoimmune disease …
Shanghai ComGen Biopharmaceutical Co., Ltd. ,Focus on the research and development of innovative drugs for new and key targets of the complement system for immunotherapy of autoimmune diseases and tumorsSee details»
上海康景生物医药科技有限公司 - comgenpharma.com
补体系统是先天性免疫的关键组成部分，也是连接先天性免疫与获得性免疫的重要桥梁。它的基本生理功能为清除入侵的病原体、细胞碎片和免疫复合物，同时还协调整个免疫和炎症反应。See details»
ComGen Biopharmaceutical - Crunchbase Company Profile
Contact Email admin@comgenpharma.com Phone Number +86-21-68822018 Kangjing Bio focuses on the research and development of innovative drugs for the immunotherapy of …See details»
Vision_Shanghai ComGen Biopharmaceutical Co., Ltd.
Vision-Shanghai ComGen Biopharmaceutical Co., Ltd. Address: Room 1202, 781 Cailun Road, Pudong New Area, Shanghai, ChinaSee details»
创新药物研发_自身免疫性疾病治疗_肿瘤的免疫治疗_上海康景生物 …
抗体筛选平台. 成熟而高效的抗体筛选平台，对于获得高亲和力、高特异性的抗体药物是必不可少的。康景拥有包括酵母展示及噬菌体展示在内的多个筛选系统，配合不同的文库以及筛选策 …See details»
ComGen Pharma Company Profile 2024: Valuation, …
ComGen Pharma General Information Description. Developer of complement therapeutic drugs. The company focuses on the research and development of innovative drugs for new and key targets of the complement system for the …See details»
Shanghai Kangjing Biomedical Technology Co., Ltd.
每周药品注册受理数据，分门别类呈现，一目了然。(4.24-5.7）新药上市申请药品名称企业名称分类受理号德谷门冬双胰岛素注射液惠升生物制药股份有限公 …See details»
关于我们,技术平台,药物研发_上海康景生物医药科技有限公司
©️ 2021 上海康景生物医药科技有限公司 版权所有 沪icp备18043941号-1See details»
Contact Us_Shanghai ComGen Biopharmaceutical Co., Ltd.
Mail : admin@comgenpharma.com . Address: Room 1202, No.781, Cailun Road, Pudong New Area, Shanghai Online Message. Leave us a message, we will answer you within 24 hours. …See details»
康景生物-动脉网 - vbdata.cn
Jun 28, 2017 上海康景成立于2017年，专注于补体系统First-in-Class的药物研发。公司打造的补体系统相关药物研发平台以及药效研究平台应用前景广阔，利用该平台公司研发的全新靶点补 …See details»
药物研发_上海康景生物医药科技有限公司 - comgenpharma.com
药物研发-上海康景生物医药科技有限公司上海康景生物医药科技有限公司,专注于补体系统全新、关键靶点的创新药物研发，用于自身免疫性疾病和肿瘤的免疫治疗See details»
Overview - Compugen
Nov 5, 2024 Corporate Overview. Compugen is a clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platform to identify …See details»
about us,Technology,Drug Discovery_Shanghai ComGen …
Address: Room 1202, 781 Cailun Road, Pudong New Area, Shanghai, ChinaSee details»
上海康景 | 项目信息-36氪
上海康景成立于2017年，是一家创新药物研发生产商，专注于创新药物研发，主要用于自身免疫性疾病和肿瘤的免疫治疗，旨在为患者提供全面化的治疗服务。公司现已获得一项全新靶点补体 …See details»
全新出发——上海康景生物医药科技有限公司开启崭新篇章_上海康 …
全新出发——上海康景生物医药科技有限公司开启崭新篇章-上海康景生物医药科技有限公司-2022年10月13日，上海康景制药科技有限公司全新研发及运营总部正式启用。红杉中国等公 …See details»
上海康景生物医药科技有限公司 - comgenpharma.com
2022年10月13日，上海康景制药科技有限公司全新研发及运营总部正式启用。红杉中国等公司投资人代表、股东代表及全体员工共同参加了简约而隆重的庆典仪式。See details»
Drug Discovery_Shanghai ComGen Biopharmaceutical Co., Ltd.
Drug Discovery-Shanghai ComGen Biopharmaceutical Co., Ltd.Shanghai ComGen Biopharmaceutical Co., Ltd. ,Focus on the research and development of innovative drugs for …See details»
康景制药与夏尔巴生物达成CDMO战略合作协议，携手加速补体创 …
中国，苏州. 2022年11月18日. 专注于补体系统 创新 药物研发的 生物制药公司康景制药和中国承担过商业化生产批次最多的cdmo公司夏尔巴生物今日共同宣布，双方就康景制药补体抑制剂项 …See details»
News_News_Shanghai ComGen Biopharmaceutical Co., Ltd.
News-Shanghai ComGen Biopharmaceutical Co., Ltd. On 17th September, ComGen Biopharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has …See details»